Assignee
ONO PHARMACEUTICAL CO
JP·514 granted patents·130 pending applications·7,144 citations·filing 1973–2025
Top patents by PatentIndex Score
644 records- 0198US9439962B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2016·Granted Sep 13, 2016·67 cites·30 claims
- 0298US9402899B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2014·Granted Aug 2, 2016·93 cites·67 claims
- 0398US9393301B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2016·Granted Jul 19, 2016·76 cites·30 claims
- 0498US9073994B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2014·Granted Jul 7, 2015·217 cites·30 claims
- 0598US9067999B1Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2015·Granted Jun 30, 2015·173 cites·30 claims
- 0698US8557803B2Purinone derivativeONO PHARMACEUTICAL CO·Filed 2013·Granted Oct 15, 2013·78 cites·2 claims
- 0798US7595048B2Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1ONO PHARMACEUTICAL CO·Filed 2003·Granted Sep 29, 2009·473 cites·4 claims
- 0898US7563869B2Substance specific to human PD-1ONO PHARMACEUTICAL CO·Filed 2004·Granted Jul 21, 2009·204 cites·4 claims
- 0997US7858746B2Substance that specifically recognizes PD-1ONO PHARMACEUTICAL CO·Filed 2008·Granted Dec 28, 2010·60 cites·2 claims
- 1096US7998479B2Substance specific to human PD-1ONO PHARMACEUTICAL CO·Filed 2009·Granted Aug 16, 2011·57 cites·2 claims
- 1196US7211591B2Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredientONO PHARMACEUTICAL CO·Filed 2005·Granted May 1, 2007·21 cites·7 claims
- 1295US9242977B2Trk-inhibiting compoundONO PHARMACEUTICAL CO·Filed 2013·Granted Jan 26, 2016·83 cites·15 claims
- 1395US6677333B12H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredientONO PHARMACEUTICAL CO·Filed 2000·Granted Jan 13, 2004·89 cites·9 claims
- 1495US6110969ACycloalkyl-prostaglandin E2 derivativesONO PHARMACEUTICAL CO·Filed 1998·Granted Aug 29, 2000·57 cites·12 claims
- 1595US5698520APeptide related to human programmed cell death and DNA encoding the sameONO PHARMACEUTICAL CO·Filed 1996·Granted Dec 16, 1997·184 cites·4 claims
- 1695US4780469A(Fused) benz(thio)amides and pharmaceutical useONO PHARMACEUTICAL CO·Filed 1985·Granted Oct 25, 1988·59 cites·28 claims
- 1795US3966792AProstaglandin compoundsONO PHARMACEUTICAL CO·Filed 1974·Granted Jun 29, 1976·40 cites·9 claims
- 1895US3962312A9,11,15-Trihydroxy prost-5-enoic acid analoguesONO PHARMACEUTICAL CO·Filed 1973·Granted Jun 8, 1976·34 cites·6 claims
- 1994US10201520B2Bicyclic compound and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2017·Granted Feb 12, 2019·10 cites·6 claims
- 2094US9889114B2Bicyclic compound and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2016·Granted Feb 13, 2018·9 cites·7 claims
- 2194US7414171B2PD-1-lacking mouse and use thereofONO PHARMACEUTICAL CO·Filed 2001·Granted Aug 19, 2008·44 cites·3 claims
- 2294US5629204APeptide related to human programmed cell death and DNA encoding itONO PHARMACEUTICAL CO·Filed 1995·Granted May 13, 1997·127 cites·4 claims
- 2394US4128720AProstaglandin analoguesONO PHARMACEUTICAL CO·Filed 1976·Granted Dec 5, 1978·33 cites·5 claims
- 2493US9199997B2Purinone derivative hydrochlorideONO PHARMACEUTICAL CO·Filed 2012·Granted Dec 1, 2015·13 cites·1 claims
- 2593US8962868B2Bicyclic compound and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2013·Granted Feb 24, 2015·14 cites·11 claims
- 2693US8039674B2Compound having S1P receptor binding potency and use thereofONO PHARMACEUTICAL CO·Filed 2005·Granted Oct 18, 2011·28 cites·6 claims
- 2793US7951816B2Compound containing basic group and use thereofONO PHARMACEUTICAL CO·Filed 2005·Granted May 31, 2011·29 cites·11 claims
- 2893US6506757B1Carboxylic acid derivatives and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 1999·Granted Jan 14, 2003·57 cites·10 claims
- 2993US4021472AGuanidinobenzoic acid derivativesONO PHARMACEUTICAL CO·Filed 1975·Granted May 3, 1977·45 cites·6 claims
- 3092US7728023B2Indole compound and use thereofONO PHARMACEUTICAL CO·Filed 2006·Granted Jun 1, 2010·25 cites·6 claims
- 3192US7288558B2Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulatorONO PHARMACEUTICAL CO·Filed 2003·Granted Oct 30, 2007·35 cites·16 claims
- 3292US6262293B1ω-Cycloalkly-prostaglandin e2 derivativesONO PHARMACEUTICAL CO·Filed 1998·Granted Jul 17, 2001·48 cites·16 claims
- 3392US5439895A4-aminoquinazoline derivativesONO PHARMACEUTICAL CO·Filed 1993·Granted Aug 8, 1995·115 cites·19 claims
- 3492US5376655ADerivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredientONO PHARMACEUTICAL CO·Filed 1993·Granted Dec 27, 1994·40 cites·2 claims
- 3592US4018812A16-methylene-prostaglandin compoundsONO PHARMACEUTICAL CO·Filed 1976·Granted Apr 19, 1977·25 cites·5 claims
- 3692US2025099419A1Bicyclic compound and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2024·Application pending·0 cites
- 3791US11691968B2Compound having KDM5 inhibitory activity and pharmaceutical use thereofONO PHARMACEUTICAL CO·Filed 2022·Granted Jul 4, 2023·2 cites·3 claims
- 3891US10940134B2Bicyclic compound and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2019·Granted Mar 9, 2021·2 cites·1 claims
- 3991US9388157B2Bicyclic compound and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2014·Granted Jul 12, 2016·9 cites·7 claims
- 4091US7786161B2Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredientONO PHARMACEUTICAL CO·Filed 2008·Granted Aug 31, 2010·21 cites·4 claims
- 4191US7402605B28-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredientONO PHARMACEUTICAL CO·Filed 2003·Granted Jul 22, 2008·38 cites·4 claims
- 4291US6710205B2Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 2001·Granted Mar 23, 2004·22 cites·13 claims
- 4391US6448290B1Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 1997·Granted Sep 10, 2002·96 cites·7 claims
- 4490US12049445B2Compounds having S1P5 receptor agonistic activityONO PHARMACEUTICAL CO·Filed 2021·Granted Jul 30, 2024·2 cites·9 claims
- 4590US11919917B2Sting agonistic compoundONO PHARMACEUTICAL CO·Filed 2021·Granted Mar 5, 2024·2 cites·48 claims
- 4690US11130773B2STING agonistic compoundONO PHARMACEUTICAL CO·Filed 2019·Granted Sep 28, 2021·5 cites·5 claims
- 4790US10214540B2Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposesONO PHARMACEUTICAL CO·Filed 2018·Granted Feb 26, 2019·12 cites·11 claims
- 4890US7491748B2Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredientONO PHARMACEUTICAL CO·Filed 2002·Granted Feb 17, 2009·46 cites·5 claims
- 4990US6376484B1Tetrazole compounds and pharmaceutical agents containing such derivative as an active ingredientONO PHARMACEUTICAL CO·Filed 2000·Granted Apr 23, 2002·25 cites·17 claims
- 5090US6235780B1ω-cycloalkyl-prostaglandin E1 derivativesONO PHARMACEUTICAL CO·Filed 1999·Granted May 22, 2001·44 cites·19 claims
Showing the top 50 of 644 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →